Abiopharma

🔍 Ries Karen (Executive)

Company: Fortune Brands Innovations, Inc. (FBIN)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Sold 257 shares of Common Stock, Par Value $0.01 at $49.26 per share (Direct)
  Date: 2026-07-31 | Code: F | equity_swap_involved: false | shares_owned_after: 10,365.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects the withholding by the issuer of shares having a fair market value equal to the withholding taxes payable by the undersigned at the time the award vested and became payable, such transaction being exempt under Rule 16b-3(e).
• F2: Includes a total of 7,906 restricted stock units that have not yet vested.